Publications by authors named "Michael Culler"

Claim this Profile
P
Phase 1 clinical trial of eneboparatide, a novel PTH receptor 1 agonist.
Michel Ovize, Soraya Allas, Michael D Culler, Stephane Milano, Taha Ouldrouis

Endocr Connect· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additive effects of ALXN2420, a GH receptor antagonist, and octreotide on IGF1 suppression in vivo.
Guillaume Ravel, Xavier Gaume, Corentin Berardet, Clémentine Chalmey, Haruaki Kurasaki, Michael D Culler

Eur J Endocrinol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data.
Kathleen L Deering, Niccole J Larsen, Patrick Loustau, Blandine Weiss, Soraya Allas, Michael D Culler

Orphanet J Rare Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabis and sport: A World Anti-Doping perspective.
Thomas J Hudzik, Marilyn A Huestis, Sabina Strano Rossi, Yorck-Olaf Schumacher, Peter Harcourt, Michael Culler

Addiction· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells.
Thomas Cuny, Thomas Graillon, Célines Defilles, Rakesh Datta, Shengwen Zhang, Michael D Culler

Pituitary· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cryptic gonadotropin-releasing hormone neuronal system of human basal ganglia.
Katalin Skrapits, Miklós Sárvári, Imre Farkas, Balázs Göcz, Szabolcs Takács, Michael D Culler

Elife· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells.
Mari C Vázquez-Borrego, Fernando L-López, María A Gálvez-Moreno, Antonio C Fuentes-Fayos, Eva Venegas-Moreno, Michael D Culler

Neuroendocrinology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TBR-760, a Dopamine-Somatostatin Compound, Arrests Growth of Aggressive Nonfunctioning Pituitary Adenomas in Mice.
Heather A Halem, Ute Hochgeschwender, Jeong Keun Rih, Richard Nelson, G Allan Johnson, Michael D Culler

Endocrinology· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas.
Jean Kim, Ju Hun Oh, Heather Harlem, Michael D Culler, Cheol Ryong Ku

Endocrinol Metab (Seoul)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Somatostatin Receptor Subtype-3 (SST) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors.
Mari C Vázquez-Borrego, Vandana Gupta, Alejandro Ibáñez-Costa, Manuel D Gahete, Eva Venegas-Moreno, Michael D Culler

Clin Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors.
Aura D Herrera-Martínez, Rosanna van den Dungen, Fadime Dogan-Oruc, Peter M van Koetsveld, Michael D Culler

Endocr Relat Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.
Thomas Günther, Giovanni Tulipano, Pascal Dournaud, Corinne Bousquet, Zsolt Csaba, Michael Culler

Pharmacol Rev· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells.
Kristina B V Døssing, Christina Kjær, Jonas Vikeså, Tina Binderup, Ulrich Knigge, Michael D Culler

Genes (Basel)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines.
David Rincón-Fernández, Michael D Culler, Natia Tsomaia, Gema Moreno-Bueno, Raúl M Luque

Carcinogenesis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer.
Daniel Hormaechea-Agulla, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, Fernando L-López, Julia Carrasco-Valiente, Michael D Culler

FASEB J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.
Daniel Hormaechea-Agulla, Manuel D Gahete, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, Alejandro Ibáñez-Costa, Michael D Culler

Mol Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.
Alejandro Ibáñez-Costa, Laura M López-Sánchez, Manuel D Gahete, Esther Rivero-Cortés, Mari C Vázquez-Borrego, Michael D Culler

Sci Rep· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients.
Manuel D Gahete, David Rincón-Fernández, Mario Durán-Prado, Marta Hergueta-Redondo, Alejandro Ibáñez-Costa, Michael D Culler

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research Resource: Real-Time Analysis of Somatostatin and Dopamine Receptor Signaling in Pituitary Cells Using a Fluorescence-Based Membrane Potential Assay.
Thomas Günther, Michael Culler, Stefan Schulz

Mol Endocrinol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.
Miguel Sampedro-Núñez, Raúl M Luque, Ana M Ramos-Levi, Manuel D Gahete, Ana Serrano-Somavilla, Michael D Culler

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters.
Raul M Luque, Miguel Sampedro-Nuñez, Manuel D Gahete, Ana Ramos-Levi, Alejandro Ibáñez-Costa, Michael D Culler

Oncotarget· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas.
Raúl M Luque, Alejandro Ibáñez-Costa, Leonardo Vieira Neto, Giselle F Taboada, Daniel Hormaechea-Agulla, Michael D Culler

Cancer Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features.
Alejandro Ibáñez-Costa, Manuel D Gahete, Esther Rivero-Cortés, David Rincón-Fernández, Richard Nelson, Michael D Culler

Sci Rep· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer.
Manel Puig-Domingo, Raúl M Luque, Jordi L Reverter, Laura M López-Sánchez, Manuel D Gahete, Michael D Culler

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131.
Lex Van der Ploeg, Haley Laken, Shubh Sharma, Rakesh Datta, Heather Halem, Michael Culler

Life Sci· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis